STOCK MARKET BSE NSE

COVID-19: India supplies hydroxychloroquine to 55 coronavirus-hit countries

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

Published: 16th April 2020 10:01 PM  |   Last Updated: 16th April 2020 10:09 PM   |  A+A-

A chemist displays hydroxychloroquine tablets in New Delhi, India, Thursday, April 9, 2020. Amidst concerns over domestic shortage, India has lifted the ban on some drug exports including hydroxychloroquine. (Photo | AP)

By PTI

NEW DELHI: India is in the process of supplying anti-malarial drug hydroxychloroquine to 55 coronavirus-hit countries as grants as well as on commercial basis, official sources said on Thursday.

A number of countries including the US, Mauritius and Seychelles have already received the drug in the past few days while several others will get it by the weekend, they said.

Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.

The demand for the drug has swelled rapidly in the last few days after India decided to lift a ban on its export.

ALSO READ | Hydroxychloroquine may not be effective against COVID-19: Chinese study

In the neighbourhood, India is sending the drug to Afghanistan, Bhutan, Bangladesh Nepal, Maldives, Mauritius, Sri Lanka and Myanmar, sources said.

It is not immediately known whether Pakistan sought to procure the drug.

India is also supplying hydroxychloroquine to Zambia, Dominican Republic, Madagascar, Uganda, Burkina Faso, Niger, Mali Congo, Egypt, Armenia, Kazakhstan, Equador, Jamaica, Syria, Ukraine, Chad, Zimbabwe, France, Jordan, Kenya, Netherlands, Nigeria, Oman and Peru, the sources said.

They said it is being sent to the Philippines, Russia, Slovenia, South Africa, Sri Lanka, Tanzania, the United Arab Emirates, Uzbekistan, Urugway, Columbia, Algeria Bahamas, Mauritius and the United Kingdom.

The sources said the drug is being sent to several countries on a commercial basis while many others are getting it as India's grants.

ALSO READ | Hydroxychloroquine may not be safe for children, can be used only in some cases: Doctors

In a recent telephonic conversation, US President Donald Trump requested Prime Minister Narendra Modi to allow the sale of hydroxychloroquine tablets ordered by the US to treat the growing number of coronavirus patients in his country.

India lifted the ban on export of the drug last week, nearly two weeks after imposing a ban on its export.

The announcement on lifting of the ban came hours after Trump warned India of retaliatory action if the drug is not supplied to the US.

Indian officials claimed that the ban was lifted before Trump's remarks.

Stay up to date on all the latest Nation news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp